Skip to main content

BioCryst: Q1 Earnings Snapshot

DURHAM, N.C. (AP) — DURHAM, N.C. (AP) — BioCryst Pharmaceuticals Inc. (BCRX) on Wednesday reported a first-quarter loss of $721.8 million, after reporting a profit in the same period a year earlier.

On a per-share basis, the Durham, North Carolina-based company said it had a loss of $2.98. Losses, adjusted for research and development costs and non-recurring costs, were 3 cents per share.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 6 cents per share.

The drugmaker posted revenue of $156.4 million in the period.

BioCryst expects full-year revenue in the range of $635 million to $660 million.

BioCryst shares have climbed 16% since the beginning of the year. The stock has decreased 18% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BCRX at https://www.zacks.com/ap/BCRX

One Tech Tip: What to know about flying with lithium ion portable battery chargers

Jetting off soon for summer travels? If you're planning on bringing an extra battery charger for your phone or other devices, be aware of the latest rules when taking one on a flight. Rechargeable lithium-ion portable battery chargers, also known as power banks, come in protective enclosures of various shapes and sizes. They're a handy and popular way for getting more juice when you're on the move. But after a spate of smoke or fire incidents, U.S. and international aviation authorities have issued new guidelines and airlines have tightened up rules for passengers. Here's a guide on flying with power banks.
Read Next Story